Posted on Leave a comment

Ascites Pipeline 2024: Clinical Trials Assessment, FDA Approvals, Therapies, and Key Companies Involved by DelveInsight | YZY Biopharma, Healthgen Biotech, Grifols Therapeutics, Versantis

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Ascites pipeline constitutes 10+ key companies continuously working towards developing 10+ Ascites treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.   The Ascites Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from […]

Posted on Leave a comment

Complicated Urinary Tract Infection (cUTI) Treatment Market 2034: EMA, PDMA, FDA Approvals, Clinical Trials, Prevalence, Therapies, Companies by DelveInsight

Complicated Urinary Tract Infection (cUTI) Treatment Market Complicated Urinary Tract Infection (cUTI) companies are Pfizer, Novartis, Spero Therapeutics, Tetraphase Pharmaceuticals, Wockhardt, Venatorx Pharmaceuticals, Cubist Pharmaceuticals, Janssen, Allecra Therapeutics, Nabriva Therapeutics AG, La Jolla Pharmaceutical Company, MerLion Pharmaceuticals, PRA Health Sciences, Qilu Pharmaceutical, Meiji Seika Pharma and others. (Albany, USA) DelveInsight’s “Complicated Urinary Tract Infection (cUTI) Market […]

Posted on Leave a comment

Liver Fibrosis Treatment Market 2034: EMA, PDMA, FDA Approvals, Clinical Trials, Therapies, Epidemiology, Medication, and Companies by DelveInsight

Liver Fibrosis Treatment Market Liver Fibrosis Companies are Beijing Continent Pharmaceutical, Gilead Sciences, Galmed R&D, Hepion Pharmaceuticals, HK inno.N Corporation, Conatus Pharmaceuticals, Dr. Falk Pharma GmbH, InterMune, Bristol-Myers Squibb, Merck Sharp & Dohme LLC, Akero Therapeutics, Inc, Pfizer, AstraZeneca, and others. (Albany, USA) DelveInsight’s “Liver Fibrosis Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding […]

Posted on Leave a comment

Non-metastatic Prostate Cancer Treatment Market 2034: Clinical Trials, EMA, PDMA, FDA Approvals, Medication, Epidemiology, Therapies, Treatment, Companies by DelveInsight

Non-metastatic Prostate Cancer Treatment Market Non-metastatic Prostate Cancer companies working in the market are Candel Therapeutics, Myovant Sciences, Sumitomo Pharma, Kangpu Biopharmaceuticals, Pfizer, Janssen Pharmaceutical, Astellas Pharma and others (Albany, USA) DelveInsight’s “Non-metastatic Prostate Cancer Market Insights, Epidemiology, and Market Forecast-2034” report delivers an in-depth understanding of Non-metastatic Prostate Cancer, historical and forecasted epidemiology as […]

Posted on Leave a comment

Vernal Keratoconjunctivitis Treatment Market 2034: Clinical Trials, EMA, PDMA, FDA Approvals, Medication, Epidemiology, Therapies, Treatment, Companies by DelveInsight

Vernal Keratoconjunctivitis Treatment Market Vernal Keratoconjunctivitis Companies working in the market are Santen Pharmaceutical, Novartis, Laboratoires Thea, Allakos Inc., Santen SASl, Astellas Pharma Inc, and others (Albany, USA) DelveInsight’s “Vernal Keratoconjunctivitis Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Vernal Keratoconjunctivitis, historical and forecasted epidemiology as well as the Vernal […]

Posted on Leave a comment

Dyslipidemia Market Poised for Significant Growth from 2024 to 2034, Reports DelveInsight | Alnylam Pharma, Amarin Corp, Amgen, Bristol Myers Squibb, Cipla, CKD Bio Corporation, AstraZeneca, Merck

The Key Dyslipidemia Companies in the market include – Merck Group, Pfizer, Sanofi, Alnylam Pharmaceuticals, Amarin Corporation, Amgen, Bristol Myers Squibb, Cipla, CKD Bio Corporation, AstraZeneca, Daewoong Pharmaceutical, Daiichi Sankyo, Inc, Eli Lilly and Company, Esperion, GSK, Jw Pharmaceuticals Limited, Kadmon, a Sanofi Company, Lupin Pharmaceuticalsl, and others.   DelveInsight’s “Dyslipidemia Market Insights, Epidemiology, and […]

Posted on Leave a comment

Ibogaine by David Dardashti Partners with Bwiti Life for Groundbreaking Trip to Gabon to Deepen Understanding of Traditional Ibogaine Treatment

Ibogaine by David Dardashti, a leading provider of ibogaine therapy, today announced a collaboration with BwitiLife.com to facilitate a transformative journey to Gabon in 2025. Gavriel Dardashti, heir to the legacy of renowned ibogaine advocate David Dardashti, will embark on this expedition to connect with the Bwiti tribe, the ancestral guardians of ibogaine. This collaboration […]

Posted on Leave a comment

Radhaa Publishing House proudly announces the paperback release of ‘Embracing Aloha’ by Aros Crystos, now available at Barnes & Noble

Radhaa Publishing House is thrilled to announce the new paperback release of Embracing Aloha: Journeys of Consciousness by Aros Crystos. This immersive work is more than a love letter to Hawaii—it is a spiritual exploration that transcends borders, cultures, and time. It speaks to the universal challenges of maintaining cultural identity, respecting nature, and fostering […]

Posted on Leave a comment

Cryopyrin-Associated Periodic Syndrome Pipeline Status 2024: Clinical Trials Overview and Key Companies involved by DelveInsight | Zydus Cadila, Novartis, Inflazome, Roche, Aclaris Therapeutics

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Cryopyrin-Associated Periodic Syndrome pipeline constitutes 4+ key companies continuously working towards developing 4+ Cryopyrin-Associated Periodic Syndrome treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.   The Cryopyrin-Associated Periodic Syndrome Pipeline report embraces in-depth commercial and clinical […]

Posted on Leave a comment

MtoZ Biolabs Launches High-Sensitivity Quantitative Phosphoproteomics Service to Advance Cutting-Edge Biomedical Research

Quantitative phosphoproteomics service utilizes advanced phosphopeptide enrichment methods combined with high-sensitivity mass spectrometry to accurately quantify and identify phosphoproteins with low abundance and across a wide dynamic range. Since the late 1990s, advancements in mass spectrometry have transformed phosphoprotein research, shifting from qualitative to quantitative analysis. This evolution has made quantitative phosphoproteomics essential for understanding […]